CLINICAL_TRIALS
trial_result
· 2016-10-28
Clinical Trial Update: Bioequivalence of Two NovoLog® Formulations in Subjects With Type 1 Diabetes [Phase 1]
Summary
A Phase 1 study evaluating the bioequivalence of two NovoLog insulin aspart formulations in adults with Type 1 diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED